SC
BIO icon

Sepio Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History

Sepio Capital’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,360
Closed -$793K – 341
2020
Q4 		$793K Sell
1,360
-453
-25% -$258K 0.07% 251
2020
Q3 		$935K Hold
1,813
– – 0.1% 174
2020
Q2 		$819K Sell
1,813
-768
-30% -$339K 0.1% 173
2020
Q1 		$905K Sell
2,581
-12
-0.5% -$4.41K 0.12% 130
2019
Q4 		$959K Sell
2,593
-131
-5% -$46.2K 0.09% 156
2019
Q3 		$906K Buy
2,724
+163
+6% +$53.2K 0.09% 156
2019
Q2 		$801K Buy
2,561
+7
+0.3% +$2.1K 0.11% 152
2019
Q1 		$781K Sell
2,554
-43
-2% -$11.6K 0.11% 153
2018
Q4 		$603K Buy
+2,597
New +$697K 0.05% 174

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return